Description
Gomiliximab Antibody, Monoclonal | 21-917 | Gentaur UK, US & Europe Distribution
Product Type: Primary Antibodies
Category: Primary Antibodies, Monoclonal Antibodies
Research Area: Drug Analogues
Type: Monoclonal
Host Species: N/A
Reactivity Species: N/A
Homology: N/A
Immunology: N/A
Tested Application: N/A
Application Note: N/A
Positive Control 1: N/A
Positive Control 2: N/A
Predicted Molecular Weight: N/A
Isoform: N/A
Purification: >95%
Clonality: Recombinant Monoclonal
Clone: N/A
Isotype: IgG1,Kappa
Conjugate: Unconjugated
Physical State: N/A
Buffer: PBS buffer pH 7.5
Concentration: N/A
Storage: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at +4°C short term (1-2 weeks) . Store at -20 °C 12 months. Store at -80°C long term.
Additional Names: GOMILIXIMAB [USAN], IDEC-152, IMMUNOGLOBULIN G1, ANTI- (HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER IMMUNOGLOBULIN G1, ANTI- (HUMAN IMMUNOGLOBULIN E RECEPTOR TYPE II) (HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MACACA IRUS MONOCLONAL IDEC-152 .KAPPA.-CHAIN, DIMER LUMILIXIMAB, LUMILIXIMAB [INN], LUMILIXIMAB [MART.], LUMILIXIMAB [WHO-DD], PRIMATIZED ANTI-CD23, ST-152, GOMILIXIMAB, CD23; FCE2; CD23A; IGEBF; CLEC4J; FCErII; BLAST-2
Protein Accession: P06734
User Note: For research use only .
Background:
Loading Controls: N/A
Source: CHO cells
Purity: >95%
CAS: 357613-86-6
Shipping Condition: N/A